API
GMAB icon

Advisor Partners II’s Genmab GMAB Stock Holding History

Advisor Partners II’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$391K Buy
11,074
+1,524
+16% +$58.1K 0.02% 830
2023
Q2 		$363K Buy
9,550
+581
+6% +$23.2K 0.02% 721
2023
Q1 		$339K Buy
8,969
+57
+0.6% +$2.19K 0.02% 680
2022
Q4 		$378K Buy
8,912
+2,398
+37% +$98.8K 0.02% 605
2022
Q3 		$209K Buy
+6,514
New +$229K 0.02% 744

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Advisor Partners II's GMAB Position: Q3 2023 in Review

Advisor Partners II increased its Genmab (GMAB) stake by 16% in Q3 2023, buying an estimated $58.1K and bringing the position to 11,074 shares worth $391K. The position accounts for 0.02% of the portfolio, ranked #830.

Advisor Partners II first reported a position in GMAB in Q3 2022 and has held it in 5 quarters since. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

  • Advisor Partners II held 11,074 shares of Genmab worth $391K as of Q3 2023.
  • Advisor Partners II bought 1,524 Genmab shares in Q3 2023, an estimated $58.1K.
  • Genmab made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #830 holding.
  • Advisor Partners II first reported a position in Genmab in Q3 2022 and has held it in 5 quarters since.
  • 233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.